KKR to acquire majority stake in India’s HCG for $400 million
US-based private equity and advisory investment firm KKR & Co. Inc. will pay CVC Capital Partners $400 million to acquire a majority stake.
Health
Medical
Pharma
Drugs
Health
Medical
US regulator clears Mirum’s oral drug for reducing cholesterol deposits
Mirum Pharmaceuticals Inc.’s oral cholesterol drug for treating a rare metabolic disease has been approved by the Food and Drug Administration.
Health
Medical
Pharma
UN humanitarian aid system facing ‘greatest test’ since creation: Relief chief
The international humanitarian aid system of the United Nations, set up after the Second World War, is facing the “greatest test since creation”.
Drugs
Health
Medical
EC grants ‘conditional’ nod for Merck’s drug to treat VHL disease
HQ Team February 18, 2025: Merck and Co’s drug, for treating adult patients with kidney and pancreatic cancer, tumours and who had prior.
Climate
Health
Medical
UN says 49 bodies of possible migrants found in two Libyan mass graves
Forty-nine bodies, likely of migrants, were found in two mass graves in Libya, according to the UN agency, the International Office of Migration.
Drugs
Health
Medical
Bain Capital to buy Japan’s Mitsubishi Tanabe Pharma for $3.3 billion
Bain Capital, a US-based private investment company, will buy the pharmaceutical arm of the Mitsubishi Chemical Group Corp. for $3.3 billion, according to.
Health
Medical
Research
Just 3% of Indians say digital workplace-life balance is ‘good’
Indians are struggling to maintain a balance between digital workplace and life, with just three out of 100 individuals, according to a survey,.
Health
Medical
Pharma
Globus Medical Inc to buy US-based Nevro Corp for $250 million all cash
Globus Medical, a US-based medical device company, will buy Nevro Corp. for $250 million in an all-cash deal.
Drugs
Health
Medical
US regulator approves pig organ transplant trial to treat kidney disease
United Therapeutics Corporation, a public benefit corporation, got approval from US regulators to start a clinical trial for organ transplantation from genetically modified.
Drugs
Medical
Tailored kidney cancer trial vaccine shows recurrence-free survival
HQ Team February 6, 2025: A phase I clinical trial has shown that personalized cancer vaccines targeting driver mutations can lead to 100%.